KBC Group’s Phibro Animal Health PAHC Stock Holding History

KBC Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-519	Closed	-$29K	–	1870
2026 Q1	$29K	Buy	+519	New	+$24.7K	﹤0.01%	1802
2023 Q3	–	Sell	-1,572	Closed	-$22K	–	1944
2023 Q2	$22K	Hold	1,572	–	–	﹤0.01%	1464
2023 Q1	$24K	Hold	1,572	–	–	﹤0.01%	1481
2022 Q4	$21K	Hold	1,572	–	–	﹤0.01%	1502
2022 Q3	$21K	Hold	1,572	–	–	﹤0.01%	1511
2022 Q2	$30K	Buy	+1,572	New	+$29.8K	﹤0.01%	1496
2019 Q1	–	Sell	-4,379	Closed	-$141K	–	1430
2018 Q4	$141K	Sell	4,379 -11,683	-73%	-$441K	﹤0.01%	1160
2018 Q3	$689K	Buy	+16,062	New	+$759K	0.01%	1026
2017 Q4	–	Sell	-4,478	Closed	-$166K	–	1284
2017 Q3	$166K	Hold	4,478	–	–	﹤0.01%	1142
2017 Q2	$166K	Buy	+4,478	New	+$146K	﹤0.01%	1130

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KBC Group's PAHC Position: Q2 2026 in Review

KBC Group sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 519 shares — an estimated $29K sold.

KBC Group first reported a position in PAHC in Q2 2017 and held it in 10 quarters. The position peaked at $689K in Q3 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

KBC Group reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
KBC Group sold 519 Phibro Animal Health shares in Q2 2026, an estimated $29K.
KBC Group first reported a position in Phibro Animal Health in Q2 2017 and held it in 10 quarters.
KBC Group's Phibro Animal Health position peaked at $689K in Q3 2018.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.